Erste Asset Management Gmb H Avidity Biosciences, Inc. Transaction History

Erste Asset Management Gmb H

  • $8.15 Trillion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 26, 2024
SELL
$6.3 - $11.35 $68,670 - $123,715
-10,900 Closed
0 $0
Q3 2022

Nov 26, 2024
BUY
$15.46 - $23.43 $168,514 - $255,387
10,900 New
10,900 $182 Million
Q2 2022

Nov 26, 2024
BUY
$11.18 - $20.5 $121,862 - $223,450
10,900 New
10,900 $156 Million
Q1 2022

Nov 22, 2024
BUY
$14.2 - $23.78 $154,780 - $259,202
10,900 New
10,900 $197 Million

Others Institutions Holding RNA

# of Institutions
250
Shares Held
107M
Call Options Held
224K
Put Options Held
161K
View Full List

About Avidity Biosciences, Inc.

RNA Quotes by TradingView
  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.79B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email